Double-blind Randomised Phase I/IIb Study

Trial Profile

Double-blind Randomised Phase I/IIb Study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs Trastuzumab (Primary) ; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Pharmacokinetics
  • Acronyms Compare
  • Most Recent Events

    • 11 Feb 2015 Planned End Date changed from 1 Jun 2013 to 1 Dec 2017 according to ClinicalTrials.gov record.
    • 04 Jun 2013 Status changed from active, no longer recruiting to completed.
    • 04 Jun 2013 Pooled analysis presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top